FG-2101 (Blacksmith Medicines)

N/A

Report date: 2025/06/11 11:18:47
NME

Base Information

Drug NameFG-2101 (Blacksmith Medicines)
Drug Alias NameFG-LpxC-UTI
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsMultidrug-Resistant InfectionUrinary Tract InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesBlacksmith Medicines IncEvotec SE
Inactive CompaniesUniversity Of California San Diego
Active IndicationsMultidrug-Resistant InfectionUrinary Tract InfectionsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A